NGL Fine-Chem share news, announcements and annual reports
NSE: NGLFINEBSE: 524774Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹2,610.60.
29 Oct: open ₹2,633.60, high ₹2,647.90, low ₹2,560.40
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,614 Cr1,319th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 28.22
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.90
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.07%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.33
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,08438.9% delivered
NGL Fine-Chem share news and announcements
154 announcements, routine notices left out, newest first. Page 3 of 4.
Mar 2024
18 Mar · Board meeting
12 Mar · Updates
Feb 2024
12 Feb · Results
3 Feb · Board meeting
Nov 2023
23 Nov · Updates
10 Nov · Results
8 Nov · Analysts
Aug 2023
25 Aug · Meeting
4 Aug · Results
4 Aug · Board meeting
4 Aug · Board meeting
1 Aug · Updates
Jul 2023
26 Jul · Board meeting
18 Jul · Rating
May 2023
23 May · Legal
Exchange has sought clarification from NGL Fine-Chem Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.15 May · Updates
15 May · Results
12 May · Analysts
Mar 2023
30 Mar · Rating
Feb 2023
13 Feb · Updates
10 Feb · Results
Jan 2023
30 Jan · Board meeting
11 Jan · Rating
Nov 2022
10 Nov · Related Party Transaction
Oct 2022
29 Oct · Analysts
3 Oct · General updates
Sep 2022
29 Sep · Analysts
2 Sep · Analysts
Aug 2022
29 Aug · Analysts
24 Aug · Analysts
12 Aug · Legal
Exchange has sought clarification from NGL Fine-Chem Limited with respect to announcement dated 10-Aug-2022 informing about Resignation.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Confirmation from Director that there are no material reasons for resignation other than that disclosed 2. Resignation letter The response of the company is awaited.11 Aug · Related Party Transaction
11 Aug · General updates